» Articles » PMID: 23355839

Recognition of the Mycobacterial Cord Factor by Mincle: Relevance for Granuloma Formation and Resistance to Tuberculosis

Overview
Journal Front Immunol
Date 2013 Jan 29
PMID 23355839
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The world's most successful intracellular bacterial pathogen, Mycobacterium tuberculosis (MTB), survives inside macrophages by blocking phagosome maturation and establishes chronic infection characterized by the formation of granulomas. Trehalose-6,6-dimycolate (TDM), the mycobacterial cord factor, is the most abundant cell wall lipid of virulent mycobacteria, is sufficient to cause granuloma formation, and has long been known to be a major virulence factor of MTB. Recently, TDM has been shown to activate the Syk-Card9 signaling pathway in macrophages through binding to the C-type lectin receptor Mincle. The Mincle-Card9 pathway is required for activation of macrophages by TDM in vitro and for granuloma formation in vivo following injection of TDM. Whether this pathway is also exploited by MTB to reprogram the macrophage into a comfortable niche has not been explored yet. Several recent studies have investigated the phenotype of Mincle-deficient mice in mycobacterial infection, yielding divergent results in terms of a role for Mincle in host resistance. Here, we review these studies, discuss possible reasons for discrepant results and highlight open questions in the role of Mincle and other C-type lectin receptors in the infection biology of MTB.

Citing Articles

Preformed mincle dimers stabilized by an interchain disulfide bond in the neck region.

Liu Y, Drickamer K, Taylor M Glycobiology. 2024; 34(12).

PMID: 39361919 PMC: 11632378. DOI: 10.1093/glycob/cwae083.


Molecular Mechanisms of MmpL3 Function and Inhibition.

Williams J, Abramovitch R Microb Drug Resist. 2023; 29(5):190-212.

PMID: 36809064 PMC: 10171966. DOI: 10.1089/mdr.2021.0424.


Modulation of TDM-induced granuloma pathology by human lactoferrin: a persistent effect in mice.

Actor J, Nguyen T, Wasik-Smietana A, Kruzel M Biometals. 2022; 36(3):603-615.

PMID: 35976499 DOI: 10.1007/s10534-022-00434-0.


Mice Dually Disrupted for and Manifest Early Bacteriological Control but Late Susceptibility During Infection.

Dube J, McIntosh F, Behr M Front Immunol. 2022; 13:862992.

PMID: 35418999 PMC: 8995500. DOI: 10.3389/fimmu.2022.862992.


Novel Role for Macrophage Galactose-Type Lectin-1 to Regulate Innate Immunity against .

Naqvi K, Huante M, Saito T, Endsley M, Gelman B, Endsley J J Immunol. 2021; 207(1):221-233.

PMID: 34183369 PMC: 8702441. DOI: 10.4049/jimmunol.2001276.


References
1.
Agger E, Rosenkrands I, Hansen J, Brahimi K, Vandahl B, Aagaard C . Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One. 2008; 3(9):e3116. PMC: 2525815. DOI: 10.1371/journal.pone.0003116. View

2.
Werninghaus K, Babiak A, Gross O, Holscher C, Dietrich H, Agger E . Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. J Exp Med. 2009; 206(1):89-97. PMC: 2626670. DOI: 10.1084/jem.20081445. View

3.
Dennehy K, Willment J, Williams D, Brown G . Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol. 2009; 39(5):1379-86. PMC: 2720084. DOI: 10.1002/eji.200838543. View

4.
Geijtenbeek T, van Vliet S, Koppel E, Sanchez-Hernandez M, Appelmelk B, van Kooyk Y . Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med. 2003; 197(1):7-17. PMC: 2193797. DOI: 10.1084/jem.20021229. View

5.
Moody D, Reinhold B, Guy M, Beckman E, Frederique D, Furlong S . Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 1997; 278(5336):283-6. DOI: 10.1126/science.278.5336.283. View